Previous 10 | Next 10 |
Onconova Therapeutics (NASDAQ: ONTX ) completes enrollment in a Phase 3 clinical trial, INSPIRE , evaluating rigosertib in myelodysplastic syndromes (MDS) patients who failed to respond to chemotherapy. More news on: Onconova Therapeutics, Inc., Healthcare stocks news, Stocks on the mov...
Onconova Therapeutics (NASDAQ: ONTX ): FY GAAP EPS of -$1.49 misses by $0.68 . More news on: Onconova Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
NEWTOWN, Pa., March 24, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today reported financial res...
Top Penny Stocks To Have On Your List Right Now? Some are calling this the biggest wealth opportunity of our era. Others still think that the market could go lower. No matter which side you stand on, one thing holds true. That one thing is volatility is king right now. This week we’ve w...
NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a focus on myelodysplastic syndromes (MDS), today announced that the Company will...
Onconova ( ONTX ) develops drugs for blood cancer. The company share price has been on the downwards trend since 2014 when it failed a phase 3 clinical trial (called ONTIME) for its lead compound rigosertib. The results for the new phase 3 trials initiated in 2016 (called INSPIRE) are schedule...
NEWTOWN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that the Compa...
The following slide deck was published by Onconova Therapeutics, Inc. in conjunction with this Read more ...
Do These Make The Cut Of Penny Stocks To Buy Right Now? Penny stocks usually trade below $5, but there are other penny stocks that might be trading at even lower levels. It is possible for investors to find value from among those stocks as well but you need a good eye for quality penny stoc...
NEWTOWN, Pa., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that Dr. Steve...
News, Short Squeeze, Breakout and More Instantly...
Onconova Therapeutics Inc. Company Name:
ONTX Stock Symbol:
NASDAQ Market:
Onconova Therapeutics Inc. Website:
Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey Pines Funding expected to ...
NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in connection with the recent acquisition of Trawsfynydd Therapeutics, Inc. by Onco...
Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey Pines Funding expected to advance development of three potential best-in-class/class leading assets: viroksavir, a cap-dependent endonuclease inhibitor for influenza; tra...